BusinessGlobal Dyslipidemia Drugs Market to Decline at 10.30% CAGR between 2015 and 2023, Impending Patent Expiry to Decrease Profit Margins of Drug makers: Transparency Market ResearchBy Nasdaq OMXApr 5, 2016, 12:16 PM UTC
